BioSpace News Archive

ProMIS Neurosciences issues Chairman’s update memorandum and white paper on Alzheimer’s disease

New resources detail positive impact of aducanumab pivotal trial results and recent progress of ProMIS pipeline programs

October 24, 2019
·
5 min read
Business

Orexo Interim Report Q3 2019

Strong financials paving the way for broadening the business

October 24, 2019
·
6 min read
Business

Vertex Announces Agreement with NHS England for Access to All Licensed Cystic Fibrosis Medicines

Eligible patients in England will have access to ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor), expanded access to KALYDECO® (ivacaftor)

October 24, 2019
·
6 min read
Drug Development

Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference

Achieve Life Sciences, Inc. announced that data from the Phase 2b ORCA-1 trial will be presented at the SRNT-O Inaugural Conference.

October 24, 2019
·
5 min read
Business

West Announces Third-Quarter 2019 Results

West Pharmaceutical Services, Inc. announced its financial results for the third-quarter 2019 and updated full-year 2019 financial guidance.

October 24, 2019
·
15 min read
Drug Development

Aerie Pharmaceuticals Completes Enrollment in the Phase 2 Trial of AR-1105 (Dexamethasone Intravitreal Implant) in Patients with Macular Edema Associated with Retinal Vein Occlusion Ahead of Schedule

Aerie Pharmaceuticals, Inc. announced that patient enrollment in its Phase 2 clinical trial of AR-1105 in patients with macular edema due to retinal vein occlusion is complete several weeks ahead of schedule.

October 24, 2019
·
7 min read
Business

Cambrex Releases Selected Preliminary Third Quarter 2019 Financial Results

Cambrex Corporation announced that in connection with the debt portion of the financing for the pending acquisition by an affiliate of the Permira Funds, they are making the following third quarter 2019 preliminary unaudited financial information available to prospective lenders.

October 24, 2019
·
3 min read
Business

DaVita Inc. Schedules 3rd Quarter 2019 Investor Conference Call

DaVita Inc., announced that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 5, 2019, at 5:00 p.m. Eastern Time.

October 24, 2019
·
1 min read
Business

3M Reports Third-Quarter 2019 Results

The 3M team delivered strong operational performance in the third quarter,” said Mike Roman, 3M chairman and chief executive officer.

October 24, 2019
·
26 min read
Pharm Country

Antares Pharma Announces Two Poster Presentations at the 2019 Sexual Medicine Society Scientific Annual Meeting

Antares Pharma, Inc. announced that data from two poster presentations will be presented on Saturday October 26, 2019 at the 20th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America.

October 24, 2019
·
6 min read